Facts & Figures

Every vision has its story, and ours began more than 60 years ago. Since then, our innovations and achievements have become landmarks in dentistry worldwide. Straumann began as a family-owned institute, grew into a publicly-owned holding, and today comprises a number of leading and talented companies around the world. Our vision has always been to create more than just smiles, but lasting confidence for dentists, labs, patients, employees, partners, dental networks and the global community. 

As a leading dental provider, Straumann is renowned for innovation and quality backed by scientific evidence. To drive our mission further, Straumann and its partners have united to form the Straumann Group. By fostering international brands we raise quality and promote global excellence in dentistry. Based on a pioneering culture that promotes creativity and learning, we bring together: global reach, experience, legacy, innovative technology, and inspired professionals to increase confidence and enhance dental care worldwide. This strong legacy builds on close collaboration with leading clinics, institutes, universities, networks and communities. The Straumann Group researches, develops, manufactures and supplies dental implants, instruments, prosthetics, biomaterials and digital solutions for use in in tooth preservation, regeneration, restoration and replacement, in close and long-term collaboration with leading clinics, institutes, universities, networks and communities.

Headquartered in Basel, Switzerland, the Straumann Group employs approximately 4000 people worldwide. Its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners, featuring the global brands Straumann, Neodent, Medentika, and other fully or partly-owned partner companies.


Key figures

(in CHF million)

  2016 2015 Change (%)
Revenue 918 799 15
Gross profit  719 615 17
Operating profit 227 173 32
Operating profit excl. exceptionals 227 186 22
Net profit 230 72 221
Net profit excl. exceptionals 187 145 29
Cash generated from operating activities 185 186 (0)
Capital expenditure 46 35 33
Free cash flow 139 151 (8)
Basic EPS (in CHF) 14.68 4.52 225
Basic EPS (in CHF) excl. exceptionals
11.94 9.19 30
Employees (at year end) 3797 3471 9
Download PDF

Did you know?

1 second

Based on the volume of products sold, every second someone somewhere in the world is treated with a Straumann Group product. 

20+ million

So far, more than 20 million Straumann brand implants have been placed worldwide.


These are the survival and success rates of Straumann implants, based on several studies.*